Wearable chest patch that monitors heart mechanics for people with heart failure

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will collect 30 days of brief hourly seismocardiography (SCG) and electrocardiography (ECG) recordings from participants wearing a small sensor on the sternum. Adults aged 18–90 with NYHA class II–IV heart failure will wear the patch after discharge or a clinic visit, complete questionnaires at the start and end, and undergo echocardiography on both visits. Sensor-derived SCG/ECG parameters will be analyzed alongside echocardiography, total blood volume estimates, medication changes, and hospitalizations. The aim is to see whether external sensor signals correlate with mechanical and clinical changes and whether early alterations can be detected.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* NYHA Class II or higher
* 18-90 years old

Exclusion Criteria:

* Pregnancy
* Drug addiction defined as the use of cannabis, opioids, or other drugs
* Mechanical heart valves
* In dialysis
* Not possible to obtain clinical echocardiography of sufficient quality
* Lack of ability to coorperate

Where it's running

• Aalborg University Hospital
  Aalborg, Denmark, Denmark Recruiting
• Copenhagen University Hospital Herlev
  Herlev, Denmark, Denmark Recruiting

Study contacts

• Study coordinator: Samuel Schmidt, MSc, PhD
• Email: sschmidt@hst.aau.dk
• Phone: +4599407456

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding Exacerbations in Heart Failure: Monitoring with Apple Watch

  This study tests whether data from an Apple Watch, combined with clinical information, can help predict worsening heart failure in adults living with the condition.

  Recruiting University Health Network, Toronto · Newmarket, Ontario and 2 other locations · NCT07447908

• Using urine sodium to guide IV diuretic dosing for hospitalized acute heart failure

  This trial will test whether increasing IV diuretic doses to reach higher urine sodium levels helps hospitalized adults with acute decompensated heart failure remove more salt and fluid and have fewer readmissions.

  Recruiting Phase 4 Lakeland Regional Health Systems, Inc. · Lakeland, Florida · NCT07263035

• Can liver stiffness testing help detect high central venous pressure in heart failure patients

  A non-invasive FibroScan test is being used to see if liver stiffness can indicate elevated central venous pressure in adults with heart failure.

  Recruiting at 6 sites Echosens · Los Angeles, California and 6 other locations · NCT07222813

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

  Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.